GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » CardioGenics Holdings Inc (OTCPK:CGNH) » Definitions » Pretax Margin %

CardioGenics Holdings (CardioGenics Holdings) Pretax Margin % : % (As of Jan. 2016)


View and export this data going back to 2004. Start your Free Trial

What is CardioGenics Holdings Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. CardioGenics Holdings's Pre-Tax Income for the three months ended in Jan. 2016 was $-0.13 Mil. CardioGenics Holdings's Revenue for the three months ended in Jan. 2016 was $0.00 Mil. Therefore, CardioGenics Holdings's pretax margin for the quarter that ended in Jan. 2016 was %.

The historical rank and industry rank for CardioGenics Holdings's Pretax Margin % or its related term are showing as below:


CGNH's Pretax Margin % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: -12.805
* Ranked among companies with meaningful Pretax Margin % only.

CardioGenics Holdings Pretax Margin % Historical Data

The historical data trend for CardioGenics Holdings's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CardioGenics Holdings Pretax Margin % Chart

CardioGenics Holdings Annual Data
Trend Jul06 Jul07 Jul08 Oct09 Oct10 Oct11 Oct12 Oct13 Oct14 Oct15
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -131,600.00 - - -

CardioGenics Holdings Quarterly Data
Apr11 Jul11 Oct11 Jan12 Apr12 Jul12 Oct12 Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Jul15 Oct15 Jan16
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of CardioGenics Holdings's Pretax Margin %

For the Diagnostics & Research subindustry, CardioGenics Holdings's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CardioGenics Holdings's Pretax Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, CardioGenics Holdings's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where CardioGenics Holdings's Pretax Margin % falls into.



CardioGenics Holdings Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

CardioGenics Holdings's Pretax Margin for the fiscal year that ended in Oct. 2015 is calculated as

Pretax Margin=Pre-Tax Income (A: Oct. 2015 )/Revenue (A: Oct. 2015 )
=-1.916/0
= %

CardioGenics Holdings's Pretax Margin for the quarter that ended in Jan. 2016 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jan. 2016 )/Revenue (Q: Jan. 2016 )
=-0.125/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CardioGenics Holdings  (OTCPK:CGNH) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


CardioGenics Holdings Pretax Margin % Related Terms

Thank you for viewing the detailed overview of CardioGenics Holdings's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


CardioGenics Holdings (CardioGenics Holdings) Business Description

Traded in Other Exchanges
N/A
Address
6295 Northam Drive, Unit 8, Mississauga, ON, CAN, L4V 1W8
CardioGenics Holdings Inc is a biotechnology company. It is engaged in the development and commercialization of diagnostic test products for the In-Vitro Diagnostics (IVD) testing market. The company's objective is to create, develop and commercialize superior, innovative, cost-effective and patent-protected products for the IVD based on proprietary technologies. Its products include QL Care Analyzer, Immunoassay Tests, and Paramagnetic Beads. The business activity is primarily carried out through the region of Canada.

CardioGenics Holdings (CardioGenics Holdings) Headlines

No Headlines